Created in 2010 (United States), HALOZYME THERAPEUTICS own 3 sister brands and 2214 competing brands. The HALOZYME THERAPEUTICS brand is owned by Halozyme Therapeutics, a company listed in New York. HALOZYME THERAPEUTICS belongs to the Biotechnology business sector.

HALOZYME THERAPEUTICS is a brand of Halozyme Therapeutics (HALO) Share price

International deposit : 2010 Business sector Biotechnology

Share price and profitability of the share Halozyme Therapeutics (HALOZYME THERAPEUTICS)

Buy Halozyme Therapeutics share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 39.12

Portfolio valuation
Halozyme Therapeutics over 5 years* USD 94.06

Stock market history Halozyme Therapeutics (HALOZYME THERAPEUTICS)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Halozyme Therapeutics

See more brands of Halozyme Therapeutics

Rival brands
HALOZYME THERAPEUTICS

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS